EZH2 Expression and its Correlation with Clinicopathological Features in Patients with Colorectal Carcinoma
作者： Xiao-yang Liu , Hua Liu , Lin Gu , Hai-lun Zheng
关键词: EZH2 、 Colorectal cancer 、 In patient 、 Clinicopathological features 、 Immunohistochemistry 、 Pathology 、 Biology 、 Expression (architecture) 、 Correlation
摘要:
core.ac.uk 
sci-hub.se 参考文章(10)
Sabine Tejpar, Lin Shen, Xicheng Wang, Richard L. Schilsky, Integrating biomarkers in colorectal cancer trials in the West and China Nature Reviews Clinical Oncology. ,vol. 12, pp. 553- 560 ,(2015) , 10.1038/NRCLINONC.2015.88
Michael T McCabe, Caretha L Creasy, EZH2 as a potential target in cancer therapy. Epigenomics. ,vol. 6, pp. 341- 351 ,(2014) , 10.2217/EPI.14.23
Erik S. Knudsen, Agnes Witkiewicz, EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer. Cell Cycle. ,vol. 12, pp. 2042- 2050 ,(2013) , 10.4161/CC.25065
Ø Fluge, , K Gravdal, E Carlsen, B Vonen, K Kjellevold, S Refsum, R Lilleng, T J Eide, T B Halvorsen, K M Tveit, A P Otte, L A Akslen, O Dahl, Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. ,vol. 101, pp. 1282- 1289 ,(2009) , 10.1038/SJ.BJC.6605333
Kunli Zhu, Shumei Jiang, Hongjiang Yan, Jinming Yu, Xiangjiao Meng, Zhaoqin Huang, Renben Wang, Yuhong Jiao, Huijuan Li, Xiaoqing Xu, Rui Feng, The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy Radiation Oncology. ,vol. 9, pp. 188- 188 ,(2014) , 10.1186/1748-717X-9-188
Y. Kondo, Targeting histone methyltransferase EZH2 as cancer treatment. Journal of Biochemistry. ,vol. 156, pp. 249- 257 ,(2014) , 10.1093/JB/MVU054
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal, Cancer statistics, 2013 CA: A Cancer Journal for Clinicians. ,vol. 63, pp. 11- 30 ,(2013) , 10.3322/CAAC.21166
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal, Cancer statistics, 2015. CA: A Cancer Journal for Clinicians. ,vol. 65, pp. 5- 29 ,(2015) , 10.3322/CAAC.21254
E.A. Reijm, A.M. Timmermans, M.P. Look, M.E. Meijer-van Gelder, C.K. Stobbe, C.H.M. van Deurzen, J.W.M. Martens, S. Sleijfer, J.A. Foekens, P.M.J.J. Berns, M.P.H.M. Jansen, High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer Annals of Oncology. ,vol. 25, pp. 2185- 2190 ,(2014) , 10.1093/ANNONC/MDU391
Wanqing Chen, Rongshou Zheng, Peter D. Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He, Cancer statistics in China, 2015 CA: A Cancer Journal for Clinicians. ,vol. 66, pp. 115- 132 ,(2016) , 10.3322/CAAC.21338